Global

Nov 12, 2021

Periodic update on transaction details related to Philips’ share repurchases

Amsterdam, the NetherlandsRoyal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from November 5, 2021 up to and including November 11, 2021 a total of 1,053,000 of its own common shares were repurchased, with a weighted average purchase price of EUR 41.40. These repurchases were made under the repurchase program for capital reduction purposes, which was announced on July 26, 2021. Since the start of the program, Philips also entered into a number of forward transactions, with settlement dates in 2022, 2023 and 2024. Further details can be found via this link.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read moreClick here to read less

Topics

Contacts

Martijn van der Starre

Martijn van der Starre

Philips Global Press Office

Tel: +31 6 2847 4617

Derya Guzel

Derya Guzel

Philips Investor Relations

Tel: +31 20 59 77055

Press releases

Get our press releases by e-mail

Share on social media

  • https://www.philips.com/a-w/about/news/archive/standard/news/press/2021/20211112-periodic-update-on-transaction-details-related-to-philips-share-repurchases.html Link copied

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.